Study explores nanoparticle approach to pharmaceutical wastewater pollution

A study published in Scientific Reports has highlighted the potential of combining marine bacteria with biosynthesised nanoparticles to help tackle pharmaceutical wastewater pollution.

The team of researchers in India investigated whether cerium oxide nanoparticles produced using the halophilic bacterial strain Halomonas venusta could improve degradation of pharmaceutical contaminants and phenolic compounds in sewage wastewater.

The study comes amid growing concern over pharmaceutical residues in waterways and the limitations of conventional wastewater treatment systems in removing active compounds.

The authors of the paper described pharmaceutical contaminants as an “emerging environmental concern” due to their persistence in aquatic ecosystems and the challenges associated with conventional remediation approaches.

According to the study, the biologically synthesised nanoparticles demonstrated significant degradation activity against contaminants present in wastewater samples. Researchers also reported reductions in phytotoxicity following treatment, suggesting the process could help lower environmental toxicity associated with pharmaceutical effluent discharge.

The paper stated that the approach offers “an eco-friendly and sustainable remediation strategy” for pharmaceutical wastewater treatment. Researchers used a halophilic bacterial strain isolated from marine environments to biosynthesise cerium oxide nanoparticles before applying them to sewage wastewater samples in a bioreactor system.

[The] treatment led to measurable improvements in contaminant degradation and wastewater quality indicators [and] the findings demonstrate the potential application of biosynthesised nanoparticles in environmental remediation”

The study found that treatment led to measurable improvements in contaminant degradation and wastewater quality indicators. The authors said the findings demonstrate the “potential application of biosynthesised nanoparticles in environmental remediation”.

Growing concerns around pharmaceutical contamination in waterways have increased pressure on manufacturers and wastewater operators to identify more sustainable treatment technologies capable of removing trace active pharmaceutical ingredients and associated pollutants.

The researchers noted that conventional treatment methods can face challenges linked to operational costs, sludge generation and incomplete degradation of contaminants. In contrast, biological and nanotechnology-based remediation approaches are attracting attention because of their potential efficiency and lower environmental impact.

The paper concluded that the findings support further investigation into biologically synthesised nanoparticles for wastewater remediation applications. However, the authors noted that additional work will be required to evaluate large-scale implementation and long-term operational performance.

The researchers wrote that the study “highlights the importance of integrating nanotechnology and microbial biotechnology for sustainable environmental management”.